Zodon 150 mg Chewable Tablets for Dogs

None

Special precautions for safe use in the target species:
The chewable tablets are flavoured. In order to avoid any accidental ingestion,
store tablets out of reach of the animals.
Use of the veterinary medicinal product should be based on susceptibility testing of
the bacteria isolated from the animal.
Official and local antimicrobial policies should be taken into account when the
product is used.
Use of the veterinary medicinal product deviating from the instructions given in the
SPC may increase the prevalence of bacteria resistant to clindamycin and may
decrease the effectiveness of treatment with lincomycin or macrolide
antimicrobials due to the potential for cross-resistance.
Clindamycin and erythromycin show parallel resistance. Partial cross-resistance
has been demonstrated between clindamycin, erythromycin and other macrolide
antibiotics.
During prolonged therapy of one month or greater, periodic liver and kidney
function tests and blood counts should be performed.
Animals with severe renal and/or very severe hepatic disturbances accompanied
by severe metabolic aberrations should be dosed with caution and should be
monitored by serum examination during high-dose clindamycin therapy.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
People with known hypersensitivity to lincosamides (lincomycin and
clindamycin) should avoid contact with the veterinary medicinal product.
Wash hands after handling tablets.
Accidental ingestion may result in gastro-intestinal effects such as abdominal
pain and diarrhoea. Care should be taken to avoid accidental ingestion
In case of accidental ingestion, particularly by children, seek medical
advice immediately and show the package leaflet or the label to the physician.
Special precautions for the protection of the environment:
Not applicable.